Home > Clinical Trials

Saved trials

RECRUITING
NCT05868226
PRE-I-SPY Phase I/Ib Oncology Platform Program
54 Enrollment(s)
6 Study location(s)
INTERVENTIONAL (PHASE1)
HER2-positive Breast Cancer


Metastatic Cancer


Metastatic Breast Cancer


Metastatic


HER2-positive Metastatic Breast Cancer


HER2 Mutation-Related Tumors


HER-2 Protein Overexpression


HER2-negative Breast Cancer


Triple Negative Breast Cancer


HR Positive


Hormone Receptor-positive Breast Cancer


Estrogen Receptor Positive Tumor


Progesterone Receptor-positive Breast Cancer


Hormone Receptor Negative Breast Carcinoma


Solid Tumor


Solid Tumor, Adult


Solid Carcinoma


HER2 Low Breast Cancer


HER2 Low Breast Carcinoma


ER Positive Breast Cancer


PR-positive Breast Cancer
연구종결
KCT0004754
자가인식 앱 피드백 시스템을 통한 edoxaban 약물 순응도 향상 연구: 무작위대조군연구
500 Enrollment(s)
1 Study location(s)
중재연구 (해당사항없음)
RECRUITING
NCT06386263
HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada
75 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Unresectable Breast Cancer


Metastatic Breast Cancer


HER2-low Expressing Breast Cancer


HER2-positive Breast Cancer
RECRUITING
NCT06409390
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
15 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (EARLY_PHASE1)
Metastatic Breast Cancer
TERMINATED
NCT06231693
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
2 Enrollment(s)
2 Study location(s)
OBSERVATIONAL (None)
Breast Cancer
COMPLETED
NCT05149014
Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast Cancer
306 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
HER2-positive Breast Cancer
NOT_YET_RECRUITING
NCT06613191
Colonoscopy and Antiplatelet Therapy Trial
100 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)


Peripheral Vascular Disease
RECRUITING
NCT04553770
Trastuzumab Deruxtecan Alone or in Combination with Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
88 Enrollment(s)
9 Study location(s)
INTERVENTIONAL (PHASE2)
Early-stage Breast Cancer


Hormone Receptor Positive Breast Carcinoma


Invasive Breast Cancer


Stage II Breast Cancer


Stage IIA Breast Cancer


Stage IIB Breast Cancer


Stage III Breast Cancer